Associated Papers
Tumor-derived ARHGAP35 mutations enhance the Gα13-Rho signaling axis in human endometrial cancer.
Yagi H et al.
Cancer Gene Therapy, 2023
p190A inactivating mutations cause aberrant RhoA activation and promote malignant transformation via the Hippo-YAP pathway in endometrial cancer.
Wen X et al.
Signal Transduction and Targeted Therapy, 2020
Select a paper to view details